Paper41599141
Breaking Barriers: Immune Checkpoint Inhibitors in Breast Cancer.
Dmuchowski B and 8 others. Pharmaceutics, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Breaking Barriers: Immune Checkpoint Inhibitors in Breast Cancer. Papers, record 41599141. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41599141
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References202
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37111371 | Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37111371 | PubMed |
| 2 | 31105877 | Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer. | Oncotarget | 2019 | https://conductscience.org/library/papers/31105877 | PubMed |
| 3 | 29443960 | TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. | Nature | 2018 | https://conductscience.org/library/papers/29443960 | PubMed |
| 4 | 37806087 | Why Treg should be the focus of cancer immunotherapy: The latest thought. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37806087 | PubMed |
| 5 | 25214542 | The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. | Ann Oncol | 2015 | https://conductscience.org/library/papers/25214542 | PubMed |
| 6 | 33002436 | Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial. | Lancet Oncol | 2020 | https://conductscience.org/library/papers/33002436 | PubMed |
| 7 | 32103175 | Epigenetic therapy inhibits metastases by disrupting premetastatic niches. | Nature | 2020 | https://conductscience.org/library/papers/32103175 | PubMed |
| 8 | 21436444 | Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. | Science | 2011 | https://conductscience.org/library/papers/21436444 | PubMed |
| 9 | 25616355 | The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis. | Breast Cancer Res Treat | 2015 | https://conductscience.org/library/papers/25616355 | PubMed |
| 10 | 30941308 | Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy. | Front Oncol | 2019 | https://conductscience.org/library/papers/30941308 | PubMed |
| 11 | 31005381 | The Abscopal Effect of Stereotactic Radiotherapy and Immunotherapy: Fool's Gold or El Dorado? | Clin Oncol (R Coll Radiol) | 2019 | https://conductscience.org/library/papers/31005381 | PubMed |
| 12 | 32527117 | Neoadjuvant treatment for HER2-positive breast cancer. | Chin Clin Oncol | 2020 | https://conductscience.org/library/papers/32527117 | PubMed |
| 13 | 40281554 | Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40281554 | PubMed |
| 14 | 30345906 | Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. | N Engl J Med | 2018 | https://conductscience.org/library/papers/30345906 | PubMed |
| 15 | 37817263 | Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms. | Breast Cancer Res | 2023 | https://conductscience.org/library/papers/37817263 | PubMed |
| 16 | 30203045 | Immunological differences between primary and metastatic breast cancer. | Ann Oncol | 2018 | https://conductscience.org/library/papers/30203045 | PubMed |
| 17 | 33588426 | CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours. | Nature | 2021 | https://conductscience.org/library/papers/33588426 | PubMed |
| 18 | 34439387 | Tumor Microenvironment in Breast Cancer-Updates on Therapeutic Implications and Pathologic Assessment. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34439387 | PubMed |
| 19 | 28650338 | IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28650338 | PubMed |
| 20 | 30217563 | Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies. | Cancer Lett | 2018 | https://conductscience.org/library/papers/30217563 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CTLA4 | 1493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| LAG3 | 3902 | PubTator's text mining | https://conductscience.org/library/genes/3902 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41599141
GET https://conductscience.org/api/papers/v1/41599141/references?page=2